Bio-Rad Laboratories, Inc. (BIO)
USD 323.94
(-4.12%)
USD 323.94
(-4.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 374.94 Million | 194.44 Million | 656.52 Million | 575.32 Million | 457.89 Million | 285.49 Million |
| Net Income | -637.32 Million | -3.62 Billion | 4.24 Billion | 3.8 Billion | 1.75 Billion | 360.99 Million |
| Depreciation & Amortization | 192.4 Million | 137.29 Million | 133.8 Million | 138.12 Million | 134.23 Million | 138.08 Million |
| Deferred income taxes | -322.6 Million | -1.24 Billion | -51.2 Million | -41.6 Million | -35.6 Million | 118.92 Million |
| Stock-based compensation | 61.3 Million | 60.9 Million | 51.2 Million | 41.6 Million | 35.6 Million | 27.8 Million |
| Change in working capital | -127.63 Million | -407.03 Million | 13.93 Million | 51.67 Million | 55.39 Million | -37.29 Million |
| Other non-cash items | 1.2 Billion | 5.27 Billion | -3.73 Billion | -3.42 Billion | -1.49 Billion | -323.02 Million |
| Investing Cash Flow | 20.2 Million | -1.2 Billion | -784.43 Million | -60.25 Million | -208.88 Million | -186.97 Million |
| Investments in PPE | -156.68 Million | -114.15 Million | -120.8 Million | -98.92 Million | -98.53 Million | -129.82 Million |
| Acquisitions | 2.71 Million | -100.74 Million | -125.51 Million | -96.65 Million | -79.38 Million | 6.96 Million |
| Investment purchases | -689.04 Million | -2.06 Billion | -1.3 Billion | -345.11 Million | -450.83 Million | -370.75 Million |
| Sales/Maturities of investments | 361.27 Million | 1.06 Billion | 766.89 Million | 368.05 Million | 331.53 Million | 266 Thousand |
| Other Investing Activities | 501.93 Million | 1.52 Million | 52 Thousand | 112.37 Million | 88.33 Million | 306.37 Million |
| Financing Cash Flow | -425.64 Million | 973.57 Million | -55.42 Million | -523.04 Million | -22.75 Million | -48.68 Million |
| Debt repayment | -467 Thousand | -510 Thousand | -3.02 Million | -426.93 Million | -643 Thousand | -2.96 Million |
| Dividends payments | -100.1 Billion | - | - | - | - | - |
| Common Stock Repurchased | -428.72 Million | -215.67 Million | -49.99 Million | -112.93 Million | -28 Million | -57.77 Million |
| Common Stock Issuance | 18.48 Million | 69.58 Billion | 35.28 Billion | 20.19 Million | 3.83 Billion | 14.13 Million |
| Other Financing Activities | 100.08 Billion | -212.13 Million | -2.41 Million | 16.83 Million | 5.88 Million | 12.05 Million |
| Accounts receivables | 11.4 Million | -87.4 Million | -20.4 Million | -15 Million | 1.6 Million | 59.7 Million |
| Accounts payables | -51.8 Million | -94.2 Million | 69.9 Million | 124.7 Million | 10.6 Million | -45.6 Million |
| Inventory | -46.3 Million | -158.8 Million | 46.1 Million | -52.1 Million | 24.2 Million | -12.9 Million |
| Other working capital | -40.93 Million | -66.63 Million | -81.66 Million | -5.92 Million | 18.99 Million | -38.49 Million |
| Cash at beginning of period | 434.22 Million | 471.13 Million | 667.11 Million | 662.65 Million | 434.16 Million | 384.98 Million |
| Cash at end of period | 403.96 Million | 434.54 Million | 471.13 Million | 667.11 Million | 662.65 Million | 434.16 Million |
| Capital Expenditure | -156.68 Million | -114.15 Million | -120.8 Million | -98.92 Million | -98.53 Million | -129.82 Million |
| Effect of forex changes on cash | 321 Thousand | 2.98 Million | -12.63 Million | 12.42 Million | 2.23 Million | -655 Thousand |
| Net cash flow / Change in cash | -30.26 Million | -36.58 Million | -195.98 Million | 4.46 Million | 228.48 Million | 49.18 Million |
| Free Cash Flow | 218.26 Million | 80.29 Million | 535.71 Million | 476.4 Million | 359.36 Million | 155.66 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.7 Billion | -2.16 Billion | 383.91 Million | -637.32 Million | 349.7 Million | 106.26 Million |
| Depreciation & Amortization | 17.99 Million | 46.6 Million | 47.8 Million | 192.4 Million | 53 Million | 37.32 Million |
| Deferred income taxes | 575.1 Million | -659.3 Million | 84.2 Million | -322.6 Million | 74.8 Million | -15.9 Million |
| Stock-based compensation | -30.3 Million | 15 Million | 15.3 Million | 61.3 Million | 16.2 Million | 15.9 Million |
| Change in working capital | 52.39 Million | -24.06 Million | -28.32 Million | -127.63 Million | -93.86 Million | 360.47 Million |
| Other non-cash items | -2.15 Billion | 3 Billion | -307.01 Million | 1.2 Billion | -318.8 Million | -406.35 Million |
| Investing Cash Flow | -55.63 Million | -30.92 Million | -43.09 Million | 20.2 Million | 72.19 Million | -9.5 Million |
| Investments in PPE | 82.45 Million | -42.28 Million | -40.17 Million | -156.68 Million | -42.24 Million | -44.07 Million |
| Acquisitions | -92 Thousand | 66 Thousand | 26 Thousand | 2.71 Million | 2.6 Million | 44.07 Million |
| Investment purchases | -399.11 Million | -248.08 Million | -406.45 Million | -689.04 Million | -151.5 Million | -196.01 Million |
| Sales/Maturities of investments | 407.06 Million | 259.37 Million | 403.51 Million | 361.27 Million | -238.6 Million | 230.52 Million |
| Other Investing Activities | -145.94 Million | 11.35 Million | 26 Thousand | 501.93 Million | 501.93 Million | -44 Million |
| Financing Cash Flow | -96.6 Million | -96.58 Million | 638 Thousand | -425.64 Million | -200.62 Million | -26.59 Million |
| Debt repayment | -236 Thousand | -118 Thousand | -118 Thousand | -467 Thousand | -118 Thousand | -118 Thousand |
| Dividends payments | -15.83 Million | - | -15.83 Million | -100.1 Billion | -85.43 Billion | - |
| Common Stock Repurchased | 105.74 Million | -101 Million | -4.74 Million | -428.72 Million | -200 Million | -21.32 Million |
| Common Stock Issuance | -10.18 Million | 4.68 Million | 5.5 Million | 18.48 Million | 4.31 Million | 4.64 Million |
| Other Financing Activities | -176.09 Million | -152 Thousand | -617 Thousand | 100.08 Billion | 85.43 Billion | -5.15 Million |
| Accounts receivables | -33 Million | -4.4 Million | 37.4 Million | 11.4 Million | -20.2 Million | 26.4 Million |
| Accounts payables | 26.6 Million | 17.8 Million | -44.4 Million | -51.8 Million | 20.6 Million | -37.7 Million |
| Inventory | 31.2 Million | -22.4 Million | -8.8 Million | -46.3 Million | 15.4 Million | -6.4 Million |
| Other working capital | 27.59 Million | -15.06 Million | -12.52 Million | -40.93 Million | -109.66 Million | 378.17 Million |
| Cash at beginning of period | 407.29 Million | 433.33 Million | 403.96 Million | 434.22 Million | 457.92 Million | 390.48 Million |
| Cash at end of period | 412.18 Million | 407.29 Million | 433.33 Million | 403.96 Million | 403.96 Million | 458.31 Million |
| Capital Expenditure | 82.45 Million | -42.28 Million | -40.17 Million | -156.68 Million | -42.24 Million | -44.07 Million |
| Effect of forex changes on cash | -7.51 Million | 3.83 Million | 2.66 Million | 321 Thousand | -6.57 Million | 6.22 Million |
| Net cash flow / Change in cash | 4.89 Million | -26.03 Million | 29.36 Million | -30.26 Million | -53.96 Million | 67.83 Million |
| Free Cash Flow | 246.68 Million | 55.36 Million | 28.99 Million | 218.26 Million | 38.8 Million | 53.64 Million |
BENGALASM
ZRSEF
BCU
TRT
TRI
BKT